Dr. Royce C. Lin, MD

Dr. Lin practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Lin's NPI, 1063524122, was assigned on August 31, 2006. Dr. Lin graduated from Yale University School of Medicine in 2000. Dr. Lin holds California license A79349.

Dr. Lin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Lin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. The medical group on file is San Francisco Public Health Laboratory. Dmand AI also links Dr. Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lin is licensed in California.

CMS data shows 172 Medicare services from Dr. Lin across 6 procedure codes in 2024, for 81 Medicare patients. Medicare paid $14,011 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 43 patients. 63% of them have high blood pressure, and 40% have mood disorders. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 66, with 32% women.

In 2024, Dr. Lin wrote 2,903 Medicare Part D claims for 123 patients. 78% of them were for generic drugs. CMS names the drug for 2,356 of them, across 63 drugs with 11 or more claims each, at $1,327,122 in total drug cost. In 2023, CMS named 2,020 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 2 papers to Dr. Lin. The most frequent topics are HIV Infections. Dr. Lin's most frequent co-author is Jeffrey M. Birnbaum, MD, MPH.

CMS Open Payments shows 6 general payments to Dr. Lin from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $80.

Dr. Lin graduated from Yale University School of Medicine in 2000.